Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $19.37 $25.53 Friday, 10th May 2024 NTLA stock ended at $24.46. This is 1.61% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 4.85% from a day low at $24.25 to a day high of $25.42.
90 days $19.37 $34.87
52 weeks $19.37 $47.48

Historical Intellia Therapeutics Inc prices

Date Open High Low Close Volume
Jul 07, 2016 $19.03 $19.59 $18.65 $19.01 222 200
Jul 06, 2016 $19.71 $19.88 $18.75 $19.20 208 200
Jul 05, 2016 $20.68 $21.03 $19.52 $19.86 171 300
Jul 01, 2016 $21.29 $21.84 $20.87 $21.02 115 700
Jun 30, 2016 $22.70 $22.90 $20.70 $21.35 297 000
Jun 29, 2016 $24.76 $24.93 $21.77 $22.70 368 700
Jun 28, 2016 $25.70 $26.97 $24.37 $24.59 148 000
Jun 27, 2016 $26.15 $27.00 $23.69 $24.87 608 500
Jun 24, 2016 $26.54 $27.00 $25.58 $26.17 984 200
Jun 23, 2016 $26.81 $27.20 $26.00 $26.46 155 800
Jun 22, 2016 $26.75 $27.12 $25.90 $26.54 226 800
Jun 21, 2016 $27.50 $27.50 $25.33 $26.35 187 200
Jun 20, 2016 $27.55 $27.77 $27.22 $27.61 175 600
Jun 17, 2016 $26.75 $27.28 $26.50 $27.10 633 400
Jun 16, 2016 $26.62 $26.99 $26.00 $26.56 142 000
Jun 15, 2016 $26.89 $27.44 $26.25 $26.43 189 400
Jun 14, 2016 $26.19 $27.03 $25.00 $26.75 399 700
Jun 13, 2016 $27.07 $28.00 $26.29 $26.61 263 300
Jun 10, 2016 $26.66 $27.60 $26.25 $27.04 221 300
Jun 09, 2016 $28.01 $28.50 $26.85 $27.02 239 800
Jun 08, 2016 $28.85 $29.00 $28.04 $28.35 151 100
Jun 07, 2016 $29.02 $29.35 $27.08 $28.51 426 000
Jun 06, 2016 $29.68 $29.74 $29.02 $29.28 142 100
Jun 03, 2016 $28.37 $29.00 $27.08 $28.80 319 500
Jun 02, 2016 $28.79 $29.18 $27.01 $28.39 540 200
Click to get the best stock tips daily for free!

About Intellia Therapeutics Inc

Intellia Therapeutics Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemophilia A and hemophilia B, hyperoxaluria Type 1, and alpha-1 antitrypsin deficiency. Its ex vivo pipeline... NTLA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT